Investors & Media
Overview
GENFIT is a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases where there are considerable unmet medical needs, corresponding to a lack of approved treatments.
Stock Information
Upcoming Events
April 1, 2021
May 12, 2021